ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.
Revenue (Most Recent Fiscal Year) | -- |
Net Income (Most Recent Fiscal Year) | $-10.06M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | -- |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.33 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -- |
Net Margin (Trailing 12 Months) | -- |
Return on Equity (Trailing 12 Months) | -204.78% |
Return on Assets (Trailing 12 Months) | -153.48% |
Current Ratio (Most Recent Fiscal Quarter) | 1.04 |
Quick Ratio (Most Recent Fiscal Quarter) | 1.04 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 0.00 |
Book Value per Share (Most Recent Fiscal Quarter) | $0.67 |
Earnings per Share (Most Recent Fiscal Quarter) | -- |
Earnings per Share (Most Recent Fiscal Year) | -- |
Diluted Earnings per Share (Trailing 12 Months) | $-1.26 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Common Shares Outstanding | 11.04M |
Free Float | 10.51M |
Market Capitalization | $1.21M |
Average Volume (Last 20 Days) | 34.20M |
Beta (Past 60 Months) | 1.06 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 4.80% |
Percentage Held By Institutions (Latest 13F Reports) | 1.19% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |